PRP Injections & Treatment Systems in Madison, WI

prp injections for a city of 250k–500k — without a fake storefront

7.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 7.4% of adults in Madison have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Population 269,840. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and J6 documentation are ready before the first application of prp injections.

If you already “have a vendor”

• Adult arthritis here is 17% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 7.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Wisconsin.
• Chronic wounds that stall past 30 days are the typical entry point for cellular/tissue products. CDC diabetes prevalence is the epidemiologic backdrop; J6 coverage rules are the billing backdrop. Both have to be true on the same chart.
• Wisconsin is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).

Why we will not invent a Madison diabetes rate

Wisconsin shares J6 with IL, MN. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 7.4% of adults in Madison have diagnosed diabetes — 4.6 points below the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.

Do this before you expand SKUs